UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Quantitative cerebral water content mapping in hepatic encephalopathy

NeuroImage (Orlando, Fla.), 2008-07, Vol.41 (3), p.706-717

2008

Volltextzugriff (PDF)

Patients with manifest hepatic encephalopathy can reveal impaired thermal perception

Acta neurologica Scandinavica, 2015-09, Vol.132 (3), p.156-163

2015

Volltextzugriff (PDF)

Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy

Acta neurologica Scandinavica, 2010-07, Vol.122 (1), p.27-35

2010

Volltextzugriff (PDF)

Cortical activation associated with asterixis in manifest hepatic encephalopathy

Acta neurologica Scandinavica, 2014-10, Vol.130 (4), p.260-267

2014

Volltextzugriff (PDF)

Impaired cerebral oscillatory processing in hepatic encephalopathy

Clinical neurophysiology, 2008-02, Vol.119 (2), p.265-272

2008

Volltextzugriff (PDF)

Cortical origin of mini-asterixis in hepatic encephalopathy

Neurology, 2002-01, Vol.58 (2), p.295

2002

Volltextzugriff (PDF)

1H-MR Spectroscopy, Magnetization Transfer, and Diffusion-Weighted Imaging in Alcoholic and Nonalcoholic Patients with Cirrhosis with Hepatic Encephalopathy

American journal of neuroradiology : AJNR, 2006-05, Vol.27 (5), p.1019-1026

2006

Volltextzugriff (PDF)

Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study

NeuroImage (Orlando, Fla.), 2004-06, Vol.22 (2), p.541-552

2004

Volltextzugriff (PDF)

Therapeutic efficacy of L‐ornithine‐L‐aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo‐controlled, double‐blind study

Hepatology (Baltimore, Md.), 1997-06, Vol.25 (6), p.1351-1360

1997

Volltextzugriff (PDF)

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study

Journal of hepatology, 1998-05, Vol.28 (5), p.856-864

1998

Volltextzugriff (PDF)

Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes

Journal of controlled release, 2003-08, Vol.91 (1), p.173-181

2003

Volltextzugriff (PDF)

Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation

European journal of gastroenterology & hepatology, 2009-12, Vol.21 (12), p.1383-1394

2009

Volltextzugriff (PDF)

Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen

The Journal of pharmacology and experimental therapeutics, 2006-12, Vol.319 (3), p.1459

2006

Volltextzugriff (PDF)

Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines

Pharmaceutical research, 2000, Vol.17 (1), p.42-48

2000

Volltextzugriff (PDF)

Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells

Clinical cancer research, 1998-08, Vol.4 (8), p.1881-1886

1998

Volltextzugriff (PDF)

Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice

Cancer gene therapy, 2000-06, Vol.7 (6), p.870-878

2000

Volltextzugriff (PDF)

Early embryonic cells activate the alternative complement system

In vivo (Athens), 1995-03, Vol.9 (2), p.85

1995

Volltextzugriff (PDF)

Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma

Cytokines, cellular & molecular therapy., 1998-06, Vol.4 (2), p.95

1998

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(13)
Male
(11)
Middle Aged
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Aged
(8)
Adult
(7)
Animals
(7)
Mice
(7)
Neurosciences & Neurology
(7)
Hepatic Encephalopathy - Complications
(6)
Mice, Inbred C57bl
(6)
Pharmacology. Drug Treatments
(6)
Clinical Neurology
(5)
Hepatic Encephalopathy
(5)
Hepatic Encephalopathy - Physiopathology
(5)
Cancer Vaccines - Administration & Dosage
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative cerebral water content mapping in hepatic encephalopathy

Patients with manifest hepatic encephalopathy can reveal impaired thermal perception

Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy

Cortical activation associated with asterixis in manifest hepatic encephalopathy

Impaired cerebral oscillatory processing in hepatic encephalopathy

Cortical origin of mini-asterixis in hepatic encephalopathy

1H-MR Spectroscopy, Magnetization Transfer, and Diffusion-Weighted Imaging in Alcoholic and Nonalcoholic Patients with Cirrhosis with Hepatic Encephalopathy

Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study

Therapeutic efficacy of L‐ornithine‐L‐aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo‐controlled, double‐blind study

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study

Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes

Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation

Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen

Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines

Sustained cytokine delivery for anticancer vaccination: liposomes as alternative for gene-transfected tumor cells

Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice

Early embryonic cells activate the alternative complement system

Cytokine gene-modified tumor cells for prophylactic and therapeutic vaccination: IL-2, IFN-gamma, or combination IL-2 + IFN-gamma

Aktive Filter

Suchergebnisse filtern